九洲药业：选举花莉蓉为执行董事并任法人

Core Points - The company announced the convening of the 18th meeting of the 8th Board of Directors on November 12, 2025 [1] - During the meeting, Hua Lirong was elected as the director representing the company to execute company affairs [1] - Hua Lirong will also serve as the legal representative of the company, with a term lasting until the end of the current Board's term [1]